REVIVA PHARMACEUTICALS HOLDINGS, INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
10080 N WOLFE ROAD, CUPERTINO, CA, 95014
Mailing Address
10080 N WOLFE ROAD, CUPERTINO, CA, 95014
Phone
4085018881
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 30, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 30, 2026 | View on SEC |
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 25, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 24, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 19, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 18, 2026 | View on SEC |
Annual Reports
10-K
March 30, 2026
- Advancing Brilaroxazine as a potential treatment for schizophrenia
- Successfully raised $15 million in capital to sustain clinical operations
Material Events
8-K
Strategy Change
March 5, 2026
High Impact
- Aims to regain compliance with Nasdaq's $1.00 minimum bid price requirement, preventing delisting.
- Maintaining Nasdaq listing is crucial for the company's credibility, liquidity, and ability to attract institutional investors.
8-K
Financial Distress
January 23, 2026
High Impact
- Secured a critical Nasdaq listing extension until March 27, 2025, providing a temporary reprieve from delisting.
- The extension mitigates immediate severe negative financial consequences associated with delisting, preserving visibility, liquidity, credibility, and capital access.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.